Top Stories
-
Researchers had high hopes for Alzheimer’s drugs that clear amyloid from the brain, but none of the drugs have slowed the disease. Columbia’s Scott Small says he has new reasons to be optimistic.
Topic
-
A new study finds that cognitive impairment begins in the earliest stages of age-related hearing loss—when hearing is still considered normal.
Topic
-
A new study from Columbia University found that a higher level of education protected against cognitive decline in black people with a gene linked to Alzheimer’s disease.
Topic
-
A new study suggests that many different immune cells, not just T cells, are involved in triggering multiple sclerosis (MS).
Topic
Latest News
- November 19, 2018
A new program at Columbia is looking for earlier signs of ALS so that future treatments can be delivered before extensive neurological damage occurs.
Topic
- September 26, 2018
Columbia neurologists found that a test used to measure Alzheimer's disease proteins in spinal fluid can be used to determine whether patients have the disease or other forms of dementia.
Topic
- September 18, 2018
A newly discovered function for the ApoE4 gene, the strongest genetic risk factor for Alzheimer’s disease, may help explain how the gene causes cognitive decline.
Topic
- September 18, 2018
A new anti-inflammatory drug may offer hope for people with a progressive form of MS. In a phase 2 trial, the drug slowed brain atrophy in people with the disease.
Topic
- September 5, 2018
A new study suggests that, among older adults, cognitive performance changes with the seasons and peaks in late summer.
Topic
- August 21, 2018
A Mailman study of more than 1 million pregnancies in Finland reports that prenatal exposure to elevated levels of DDT is associated with an increased risk for autism.
Topic
- August 2, 2018
A new clinical trial suggests that donepezil does not improve cognitive performance in people with mild cognitive impairment who also have clinical depression.
Topic
- June 25, 2018
Mutations that only occur in some brain cells may account for a significant fraction of specific types of epilepsy, according to a new Columbia study.
Topic
- June 22, 2018
As the World Cup games continue, we talked to neurologist James Noble, MD, about the known—and unknown—risks of heading in soccer.
Topic
- June 15, 2018
In one of the first studies of its kind, Columbia’s Philip De Jager shows how "big data" analyses may lead to new treatment strategies for Alzheimer's disease.
Topic
